Encompass Health officer plans $588K stock sale

Encompass Health Corp (EHC) has a notice of proposed sale under Rule 144 for shares held for the account of officer John Patrick Darby.

Rhea-AI Filing Summary

Encompass Health Corp (EHC) has a notice of proposed sale under Rule 144 for shares held for the account of officer John Patrick Darby. The filing covers a proposed sale of 4,858 shares of common stock, to be effected through UBS Financial Services Inc. and associated with a stock option exercise, with an estimated aggregate market value of $588,255.71. The notice also reports Encompass Health common shares outstanding of 98,653,384 and discloses that Darby sold 8,906 shares of common stock over the prior three months for proceeds of $1,121,700.

Key Figures

Shares proposed to be sold: 4,858 shares of common stock Estimated aggregate market value: $588,255.71 Shares outstanding: 98,653,384 shares of common stock +3 more

6 metrics

Shares proposed to be sold 4,858 shares of common stock Proposed Rule 144 sale for account of John Patrick Darby

Estimated aggregate market value $588,255.71 Value of 4,858 shares proposed to be sold

Shares outstanding 98,653,384 shares of common stock Encompass Health common shares outstanding

Shares sold in past 3 months 8,906 shares of common stock Sales by John Patrick Darby during the past 3 months

Proceeds from past 3 months sales $1,121,700 Value of 8,906 shares sold during the past 3 months

Proposed sale date 08/31/2026 Date associated with proposed Rule 144 sale and stock option exercise

Key Terms

Rule 144, Form 144, stock option exercise, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"Common Stock | 08/31/2026 | Stock Option Exercise | Encompass Health Corporation"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common Stock | UBS Financial Services Inc ... | 588255.71"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Encompass Health Corp (EHC) disclose?

It discloses that 4,858 shares of Encompass Health common stock are proposed to be sold for the account of officer John Patrick Darby under Rule 144, related to a stock option exercise, with an estimated aggregate market value of $588,255.71.

How many Encompass Health (EHC) shares are proposed to be sold in this Form 144?

The filing reports a proposed sale of 4,858 shares of Encompass Health common stock, to be sold through UBS Financial Services Inc. in connection with a stock option exercise, with the proposed sale date listed as 08/31/2026.

What is the estimated value of the shares in the Encompass Health (EHC) Form 144?

The estimated aggregate market value of the 4,858 shares proposed for sale is $588,255.71, as stated in the Form 144 notice for Encompass Health common stock.

How many Encompass Health (EHC) shares are outstanding according to this filing?

The notice states that Encompass Health has 98,653,384 shares of common stock outstanding. This figure provides context for the size of the 4,858-share proposed sale under Rule 144.

What Encompass Health (EHC) stock sales occurred in the last 3 months for this insider?

Over the past three months, John Patrick Darby is reported to have sold 8,906 shares of Encompass Health common stock, with total proceeds of $1,121,700, according to the Form 144 disclosure.

Which broker is handling the proposed Encompass Health (EHC) Rule 144 sale?

The proposed sale of 4,858 shares of Encompass Health common stock is listed as being handled by UBS Financial Services Inc., located in Weehawken, New Jersey, as the broker in the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 12:41 PM EDT Accepted by SEC EDGAR 08/31/2026 - 12:40 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001664699
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Encompass Health Corporation
SEC File Number	001-10315
Address of Issuer	9001 Liberty Parkway Birmingham ALABAMA 35242
Phone	205-967-7116
Name of Person for Whose Account the Securities are To Be Sold	John Patrick Darby
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	4858	588255.71	98653384	08/31/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/31/2026	Stock Option Exercise	Encompass Health Corporation			4858	08/31/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Patrick Darby 3115 Overhill Road Birmingham AL 35223	Common Stock	08/10/2026	8906	1121700

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for John Patrick Darby
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)